Notice: This company has been marked as potentially delisted and may not be actively trading. Lianluo Smart (LLIT) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesTrends LLIT vs. AMIX, SNOA, STSS, NAYA, INVO, VERO, BJDX, AVGR, AFIB, and DYNTShould you be buying Lianluo Smart stock or one of its competitors? The main competitors of Lianluo Smart include Autonomix Medical (AMIX), Sonoma Pharmaceuticals (SNOA), Sharps Technology (STSS), NAYA Biosciences (NAYA), INVO Bioscience (INVO), Venus Concept (VERO), Bluejay Diagnostics (BJDX), Avinger (AVGR), Acutus Medical (AFIB), and Dynatronics (DYNT). These companies are all part of the "medical" sector. Lianluo Smart vs. Autonomix Medical Sonoma Pharmaceuticals Sharps Technology NAYA Biosciences INVO Bioscience Venus Concept Bluejay Diagnostics Avinger Acutus Medical Dynatronics Autonomix Medical (NASDAQ:AMIX) and Lianluo Smart (NASDAQ:LLIT) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, profitability, analyst recommendations, earnings, dividends, community ranking, risk and media sentiment. Does the MarketBeat Community favor AMIX or LLIT? Lianluo Smart received 103 more outperform votes than Autonomix Medical when rated by MarketBeat users. However, 100.00% of users gave Autonomix Medical an outperform vote while only 70.27% of users gave Lianluo Smart an outperform vote. CompanyUnderperformOutperformAutonomix MedicalOutperform Votes1100.00% Underperform VotesNo VotesLianluo SmartOutperform Votes10470.27% Underperform Votes4429.73% Is AMIX or LLIT more profitable? Lianluo Smart's return on equity of 0.00% beat Autonomix Medical's return on equity.Company Net Margins Return on Equity Return on Assets Autonomix MedicalN/A -542.11% -236.92% Lianluo Smart N/A N/A N/A Do institutionals & insiders hold more shares of AMIX or LLIT? 10.8% of Autonomix Medical shares are owned by institutional investors. Comparatively, 28.8% of Lianluo Smart shares are owned by institutional investors. 32.4% of Autonomix Medical shares are owned by insiders. Comparatively, 22.9% of Lianluo Smart shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the media favor AMIX or LLIT? In the previous week, Autonomix Medical had 4 more articles in the media than Lianluo Smart. MarketBeat recorded 4 mentions for Autonomix Medical and 0 mentions for Lianluo Smart. Autonomix Medical's average media sentiment score of 0.40 beat Lianluo Smart's score of 0.00 indicating that Autonomix Medical is being referred to more favorably in the media. Company Overall Sentiment Autonomix Medical Neutral Lianluo Smart Neutral Which has better valuation and earnings, AMIX or LLIT? Lianluo Smart has higher revenue and earnings than Autonomix Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAutonomix MedicalN/AN/A-$15.43M-$16.07-0.21Lianluo Smart$380K2.68-$4.45MN/AN/A Do analysts prefer AMIX or LLIT? Autonomix Medical currently has a consensus target price of $28.00, suggesting a potential upside of 748.48%. Given Autonomix Medical's stronger consensus rating and higher probable upside, equities research analysts clearly believe Autonomix Medical is more favorable than Lianluo Smart.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Autonomix Medical 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Lianluo Smart 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryAutonomix Medical beats Lianluo Smart on 7 of the 13 factors compared between the two stocks. Ad StocksToTradeLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds for a dollar anymore!Click here to review Tim’s special Holiday offer before it’s too late. Get Lianluo Smart News Delivered to You Automatically Sign up to receive the latest news and ratings for LLIT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LLIT vs. The Competition Export to ExcelMetricLianluo SmartSurgical & Medical Instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.02M$4.36B$5.20B$9.13BDividend YieldN/A44.58%5.11%4.29%P/E RatioN/A25.3687.2417.20Price / Sales2.6851.391,117.25125.12Price / CashN/A43.4043.2337.87Price / Book-0.787.114.855.01Net Income-$4.45M$13.64M$119.99M$225.06M Lianluo Smart Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LLITLianluo SmartN/A$0.46-1.1%N/A-62.1%$1.02M$380,000.000.006AMIXAutonomix Medical2.4993 of 5 stars$3.46-3.9%$28.00+709.2%N/A$3.99MN/A-0.221Short Interest ↑SNOASonoma Pharmaceuticals0.2157 of 5 stars$2.75+4.6%N/A+1,271.6%$3.68M$13.55M-0.55180Short Interest ↑STSSSharps Technology0.6095 of 5 stars$1.88+0.2%N/AN/A$3.39MN/A-0.233Short Interest ↑NAYANAYA BiosciencesN/A$0.74-1.7%N/AN/A$3.30M$6.23M0.00N/AINVOINVO BioscienceN/A$0.75-1.3%N/A-45.8%$2.86M$5.77M0.0025VEROVenus Concept2.8052 of 5 stars$0.31-4.2%N/A-70.3%$2.24M$67.20M-0.04410Gap UpBJDXBluejay Diagnostics0.648 of 5 stars$3.76-2.1%N/A-99.6%$2.08M$250,000.000.009Short Interest ↑AVGRAvinger3.3376 of 5 stars$0.59+22.3%$5.00+747.5%-54.8%$1.95M$7.26M-0.0570Short Interest ↓High Trading VolumeAFIBAcutus MedicalN/A$0.06+5.8%N/A-72.3%$1.64M$7.16M0.00340Gap DownDYNTDynatronicsN/A$0.15+9.4%N/A-79.2%$1.05M$33.60M-0.15200Gap Up Related Companies and Tools Related Companies Autonomix Medical Competitors Sonoma Pharmaceuticals Competitors Sharps Technology Competitors NAYA Biosciences Competitors INVO Bioscience Competitors Venus Concept Competitors Bluejay Diagnostics Competitors Avinger Competitors Acutus Medical Competitors Dynatronics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:LLIT) was last updated on 12/27/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lianluo Smart Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Lianluo Smart With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
